Journal of the Argentine Society of Diabetes

Controversy with interaction

Debate 2

Does the treatment of dyslipidemia differ?

Silvio Schraier

27 - 27
- PDF (Español (España))
Therapeutic algorithm for arterial hypertension

Solange Houssay

27 - 29
- PDF (Español (España))

Symposiums part 7

Early-onset obesity: monogenic obesity

María Eugenia Andrés

29 - 29
- PDF (Español (España))
Challenges in addressing adolescent obesity

Adriana Roussos

29 - 30
- PDF (Español (España))
When obesity is not experienced as a disease

Teresa Panzitta

30 - 30
- PDF (Español (España))

Miniconferences part 3

Advantages and disadvantages of adopting the value at 60´ in the oral glucose tolerance test

Graciela Pennachiotti

30 - 31
- PDF (Español (España))
Is it time to consider prediabetes and diabetes mellitus as a single entity?

Víctor Commendatore

31 - 31
- PDF (Español (España))

TALK WITH EXPERTS part 2

Insulin signaling and physical activity in skeletal muscle

Martín Pavarotti

31 - 32
- PDF (Español (España))

Conferences part 2

CONFERENCE: The evolution of diabetes: from the discovery of insulin, to DCCT and intra-thecal leptin

Irl Hirsch

32 - 32
- PDF (Español (España))

Symposiums part 8

Where is the place for insulin therapy?

Pilar Cean

32 - 33
- PDF (Español (España))
What do we do with metformin?

Alejandra Cicchitti

33 - 33
- PDF (Español (España))
Do we combine GLP-1 inhibitors + SGLT2 inhibitors? Yes or no

Claudia Folino

33 - 34
- PDF (Español (España))

Symposiums part 9

Is it increasing in Argentina?

Laura Gaete

34 - 34
- PDF (Español (España))
Paediatric steatotic liver disease

Carol Lezama

35 - 35
- PDF (Español (España))
Barriers in the treatment of type 2 diabetes in pediatrics: how to deal with them?

Mónica García Barthe

35 - 36
- PDF (Español (España))

Symposiums part 10

When to educate? What do the guides say?

María Lidia Ruiz Morosini

36 - 36
- PDF (Español (España))
What do we have to change to achieve greater adherence?

Iñaki Lorente

36 - 37
- PDF (Español (España))
Educating on the use of technology to make a difference

Gabriela Rovira

37 - 37
- PDF (Español (España))

Symposiums part 11

What is the value of early screening?

Silvia Lapertosa

37 - 38
- PDF (Español (España))
Heterogeneity at diagnosis

Susana Salzberg

38 - 38
- PDF (Español (España))
What do we know about MODY in pregnancy?

Cristina Faingold

38 - 39
- PDF (Español (España))

Latin American Table

Importance of women's health in Latin America (Paraguay)

Luis Escurra

39 - 39
- PDF (Español (España))
Importance of women's health in Latin America (Uruguay)

Andrea Ortiz

39 - 40
- PDF (Español (España))
Importance of women's health in Latin America (Chile)

Verónica Mujica

40 - 40
- PDF (Español (España))
Importance of women's health in Latin America (Perú)

Segundo Nicolás Seclen

40 - 41
- PDF (Español (España))
Importance of women's health in Latin America (Bolivia)

Lucía Lijerón Eguez

41 - 41
- PDF (Español (España))
Importance of women's health in Latin America (Argentina)

Martín Rodríguez

41 - 42
- PDF (Español (España))

4 VOICES IN 10 MINUTES part 2

Thermometry in the diabetic foot

Marcelo Almada

42 - 43
- PDF (Español (España))
Amniotic membrane dressings in the treatment of diabetic foot ulcers

Gabriela Carro

43 - 43
- PDF (Español (España))

Controversies part 2

Yes: Gabriela Krochik. No: Mabel Ferraro

Gabriela Krochik, Mabel Ferraro

43 - 44
- PDF (Español (España))

4 VOICES IN 10 MINUTES part 3

Sendas Project: Diabetes goes to school

Florencia Grabois

44 - 44
- PDF (Español (España))
Diabetes explorers: learning by playing

Laura Pomares

44 - 45
- PDF (Español (España))
Can gestational diabetes education improve perinatal outcomes?

Elizabeth Méndez

45 - 45
- PDF (Español (España))
Experience in Primary Health Care and education in type 2 diabetes mellitus

Silvia Saavedra

45 - 46
- PDF (Español (España))

4 VOICES IN 10 MINUTES part 4

Retinopathy: antiangiogenics, when and how?

Claudia Issa

46 - 46
- PDF (Español (España))
Can pre-eclampsia be prevented?

Celeste Muntaner

46 - 47
- PDF (Español (España))
Obesity and diabetes: the same risk for offspring?

Carolina Gómez Martin

47 - 47
- PDF (Español (España))
The placenta: when is it affected in maternal diabetes?

Alicia Jawerbaum

47 - 48
- PDF (Español (España))

TALK WITH EXPERTS part 3

TALK WITH EXPERTS: Which is better to use HbA1c, continuous glucose monitoring or both?

Irl Hirsch

48 - 48
- PDF (Español (España))

Symposium part 12

From pathophysiology to clinical implications

Fernando Botto

48 - 49
- PDF (Español (España))
Diabetic nephropathy: new mechanisms and pharmacological options

Alicia Elbert

49 - 49
- PDF (Español (España))
Cardiovascular risk reduction strategies in people with diabetes: what have we learned?

Ezequiel Forte

49 - 49
- PDF (Español (España))

Symposiums part 13

Whole organ transplantation

Karina Fuentes

50 - 50
- PDF (Español (España))
Automated closed loop systems or not

Luis Grosembacher

50 - 51
- PDF (Español (España))
Sarcopenia and its impact on insulin resistance

Moisés Schapira

51 - 51
- PDF (Español (España))
Management of hypoglycemic therapy in older adults: challenges and opportunities

Marcela Martínez

51 - 52
- PDF (Español (España))

Symposiums part 14

Hormone replacement treatment and cardiovascular impact

Jimena Soutelo

52 - 52
- PDF (Español (España))
Contraception in adolescents with diabetes

Gladys Fernández

52 - 53
- PDF (Español (España))
Asymptomatic bacteriuria in women with diabetes mellitus: should it be treated?

Juan Manuel Orlando

53 - 53
- PDF (Español (España))

TALK WITH EXPERTS part 4

Eating disorders and type 1 diabetes mellitus

Mariana Prieto

53 - 53
- PDF (Español (España))

4 VOICES IN 10 MINUTES part 5

Nutritional alternatives in DM1 with obesity

Natalia Presner

53 - 54
- PDF (Español (España))
Insulinization in preschoolers

Marcela Raggio

54 - 54
- PDF (Español (España))
Physical activity in type 1 diabetes mellitus in children

Daniela Rodríguez

55 - 55
- PDF (Español (España))
Transition in type 1 diabetes mellitus

María Eugenia Andrés

55 - 55
- PDF (Español (España))

Miniconferences part 4

Functional capacity: dynapenia, the cause of muscle damage and its consequences

Gustavo Diaz Gerevini

56 - 56
- PDF (Español (España))
Insulin resistance and thyroid: a reciprocal relationship

Gabriela Brenta

56 - 57
- PDF (Español (España))

Miniconferences part 5

Use of antiresorptives: increased risk of complications?

Claudia Sedlinsky

57 - 57
- PDF (Español (España))

TALK WITH EXPERTS part 5

The revolution of artificial intelligence in the digital medical office

Lucas Sosa

57 - 58
- PDF (Español (España))

TALK WITH EXPERTS part 6

Obstructive sleep apnea syndrome and diabetes

Gonzalo Peralta

58 - 58
- PDF (Español (España))

Conferences part 3

Metabolic hepatic steatosis: what the diabetologist needs to know

Kenneth Cusi

58 - 59
- PDF (Español (España))

Symposiums part 15

Managing emotional aspects. Guide from the Spanish Diabetes Society

Iñaki Lorente

59 - 59
- PDF (Español (España))
Therapeutic advances in the use of positive language

Olga Escobar

59 - 60
- PDF (Español (España))
Cognitive impairment and dementia: a new challenge in our practice

Alejandro Daín

60 - 60
- PDF (Español (España))

Symposiums part 16

Changes in male sexual function

Pablo Knoblovits

60 - 61
- PDF (Español (España))
Current treatment of male sexual dysfunction

Adolfo Casabe

61 - 61
- PDF (Español (España))
Alterations in female sexual function: the forgotten topic?

Lorena Lequi

61 - 62
- PDF (Español (España))
Gender identity, diabetes and cardiovascular risk. Endocrinological approach

Manuel Lapertosa

62 - 62
- PDF (Español (España))

Symposiums part 17

Experience in the Province of Buenos Aires

Matías Alberto Duca

62 - 63
- PDF (Español (España))

Symposiums part 18

MCG flash versus real time

Adrián Proietti

63 - 63
- PDF (Español (España))
How to use digital platforms?

María Lidia Ruiz Morosini

63 - 64
- PDF (Español (España))

Conferences part 4

Strategies for prevention and early intervention in type 1 diabetes mellitus

Chantal Mathieu

64 - 64
- PDF (Español (España))

Symposiums part 19

Signs that teach. Educational project for deaf people

Evangelina Sosa

65 - 65
- PDF (Español (España))
Training in enclosed situations

Laura Otiñano

65 - 66
- PDF (Español (España))
Education challenge in aboriginal communities

Cynthia Amott

66 - 66
- PDF (Español (España))

Symposiums part 20

Clinical simulation as a learning paradigm shift

Carla Prudencio

66 - 66
- PDF (Español (España))
Scenario design and facilitation

Lucía Poggio

67 - 67
- PDF (Español (España))

Debate part 3

The future of the health system: from curing to caring

Rubén Torres

67 - 67
- PDF (Español (España))

Minisymposiums

Smart pens/integration with continuous glucose monitoring

Javier Remon

67 - 68
- PDF (Español (España))
Open vs closed loop insulin infusion systems

Rodrigo Carnero

68 - 68
- PDF (Español (España))
Continuous glucose monitoring in type 2 diabetes mellitus

Carolina Gómez Martin

68 - 69
- PDF (Español (España))

4 SAD CHAPTERS

Introduction: Generalities of drug-induced diabetes. NEA Chapter

Javier Ceniquel

69 - 69
- PDF (Español (España))
Oncology/biological drugs. Córdoba Chapter

Karina Fuentes

70 - 70
- PDF (Español (España))
Antipsychotics and statins. Atlantic Chapter

Claudio Dituro

70 - 70
- PDF (Español (España))

Symposiums part 21

Importance of training clinical specialists. Specialization courses

Enrique Majul

71 - 71
- PDF (Español (España))

Conferences part 5

ESCUDERO LECTURE: A person with type 2 diabetes mellitus and metabolic-renal-cardiovascular syndrome. Evidence, doubts, omissions

Isaac Sinay

71- 72
- PDF (Español (España))

Selected works

Oral presentations

Argentine Diabetes Society

73 - 95
- PDF (Español (España))
Poster presentations

Argentine Diabetes Society

96 - 160
- PDF (Español (España))
ANNEX: SUBSIDIES 2022

Argentine Diabetes Society

163 - 170
- PDF (Español (España))

Bienvenidos

About the Journal

Current Issue

Full Issue

Editorial

Symposium Part 1

Symposium Part 2

Symposiums Part 3

Symposium Part 4

Conferences

Mini conferences

4 VOICES IN 10 MINUTES

Symposiums part 5

Debate

Minicontroversies

Miniconferences part 2

Symposiums part 6

TALK WITH EXPERTS

Controversy with interaction

Debate 2

Symposiums part 7

Miniconferences part 3

TALK WITH EXPERTS part 2

Conferences part 2

Symposiums part 8

Symposiums part 9

Symposiums part 10

Symposiums part 11

Latin American Table

4 VOICES IN 10 MINUTES part 2

Controversies part 2

4 VOICES IN 10 MINUTES part 3

4 VOICES IN 10 MINUTES part 4

TALK WITH EXPERTS part 3

Symposium part 12

Symposiums part 13

Symposiums part 14

TALK WITH EXPERTS part 4

4 VOICES IN 10 MINUTES part 5

Miniconferences part 4

Miniconferences part 5

TALK WITH EXPERTS part 5

TALK WITH EXPERTS part 6

Conferences part 3

Symposiums part 15

Symposiums part 16

Symposiums part 17

Symposiums part 18